Medical Director (San Antonio, TX)

About the Role

We are seeking a Medical Director-Investigator to lead clinical research initiatives with integrity, quality, and a commitment to protecting patient welfare. This pivotal role involves overseeing clinical investigations, ensuring regulatory compliance, and supervising clinical and investigative staff. If you are a leader with a passion for advancing healthcare and clinical research, this position offers a unique opportunity to make a tangible impact.

Key Responsibilities

• Protocol Compliance : Ensure adherence to study protocols and federal/state regulations, including IRB requirements.
• Medical Oversight : Manage the medical care of study participants, ensuring their rights and welfare are prioritized.
• Data Integrity : Assure the validity and quality of data reported to study sponsors.
• Team Leadership : Directly supervise Investigators and Sub-Investigators; oversee clinical staff operations.
• Operational Excellence : Ensure proper documentation of study procedures and secure storage of investigational agents.
• Collaboration : Support site operations and contribute to the success of clinical investigations through cross-functional teamwork.

What You Bring

• Minimum 2 years of experience performing physicals, assessing, and treating patients.
• Proven track record of supervising teams, with strong interpersonal and communication skills.
• Excellent organizational, planning, and documentation abilities.
• Experience in conflict resolution and a steadfast commitment to quality standards.
• Flexible availability, including on-call, weekends, and holidays, as required.
• At least 2 years of experience in clinical research as an investigator or sub-investigator, with a solid understanding of the clinical research process and Good Clinical Practices (GCP).

Qualifications

• Required : Medical degree (M.D.) with at least 2 years of clinical research experience.
• Preferred : Medical degree plus 5+ years of clinical research experience, including 2 years in Phase 1 trials.